Attach 26_BEEA IRB Approvals

ATTACHMENTS 26

IRB Approvals for the BEEA Study
26A.
26B.
26C.
26D.

NCI SSIRB
Westat – Coordinating Center
University of Iowa Field Station – Iowa Field Station
Batelle Centers for Public Health Research and Evaluation –
North Carolina Field Station

IVESTAT5g__1W00R

,"21t3109 12:59 FAX 301 29{ 2092

3
ffigrr,or*.

PRorocol
EuNrc* R€SEARcH

Michael

INTNAL RSIIEW AP PLICATION

andemail):
Tetephone
AddrBss,
lnrt.nuwErandt,

3014354
NCI/DcEG/OEEB,

pRoTOCOLflTLE:

IITLE (30chrrsetgtsor lesel
ABBREVIATEO

DAre'?2Bi1S
END

p^oroseosroRrDATE:
!lJll!--

cA. ef:!!cl:
toNlZtNG RAOIATION USE 1xap, e g, CT: adoi56seea'

MU LTI.SITE COLI.AEORATION:

No
lnts,sodion).
E Yet (complcte
i"tlauorsttofl?
r"-,-rii
F
Yes E Ho
wlil"-i"N-ii"
subicds psddPats on tne pmlocotat ihe NIH Cc? F

E Ycs O No
3t oth6rsiret
- on $B PreloEot
will
scbiecu psnic'9ale
";r.-;;il;;il
Cl sotr'
g! oot".ric
E Foraien
sile?
ls NIHlhc cootdlna$ng
namu'tdoreg6'
lnslilotlon
sib, provld€:
E
- Yes.Forsachp3nlclpErlne
indbte ir suljsas will be trcruitcd3nd lf th6yate' insude a
";0",or1g1.
notrieon sltachcdineevpr€losott3cesheol'
cmhi
El No. Coordinalingstte t6 We,stat

REouEsT€D
D None
Q MEI€

1600

ffiEg(at€drlsrgorbuctorpns6€3ir

ACCRUAL EXCLUSION (ch€ck ail tnst spglv):
O Aglsn
O Elsck or Afridn Amsrican

g whne
6i remste
I HisF ^icorLat
E cxtarcncte
tnaan/AtEskanNrrive 0 NativeH3wslbnor Pacificlslsnder
6 nn
"i*.
SUBJEF ACCRUALCHARACTERIST{CS:
ts
MlnlmumAoePermlned
Maxinufi A€e Psrmked-g:--OtlvL
D24Yr3' tr?-1?Yre'
p"oia,i"
INone
Cl No
E Yes
Pro.ocolInvolv8shealtfryvolunleaE?
ere Healhy VolunleereNIH Emplo)eec? O Yes
I I"
Bl No
tr Yss
Doesttrcprotocotpettnitge'ltr€fcr€l?
Cl Yss E No
give
inbmgd
conse^rt
W;llrheprorocolin\,€lvesltultsungblato
FF,OToCOLTYPB.(Cheskone)r
E scracning
O Tr€inrnE
- O'l3e€ee
Frogrsss'onlPltlPlolcgy.
O HarurafFtislory
Frl$d'}
or A^slysls{R€ctlJlunq
C ii","t"f ff"titi- SamPte'oslE-Collaction
F€dlJnntPircng)
6 iiiturar urEtori - lamprdosn coflec{,onor An3lveJJ(Na'(
amies
O PharmocoKnettcuoyfl
O 6iink:t Tdrl: ldentlf/PhasB(check one)
I
E Phsse1'2
Pheee
O
Phoseo
O
E Phasea
El Pnste3
D Phass2

6-il-'--o
'comoalc

*

chscksllllBrtFFty

Med-drliinaicsred,

?R"^tT':Li:F:.d:.^^-,,^,
$tie potocoland
NIH€g.?Ja,:nd rrllch lo Gk sFtlirsuon'ScndI copyd
rg'rs''
NIH€de3s b chslr. Rartlat'cdssr$y lor coGurGil
v

rltsvrw?

riY:---

F

EIND
SNone
INVESTIGATIONALNEWDRUG'oEVICE:
" ' - -- ir ttoorrnE
li8(m ttBch€dsnsst
froGth!fionsINO/1O6,
No.
FOA
tNDrlDEN3me:
Sponsol:

IhE

Who is ttE msnutBcture. otths abo\c efilDr

B No

O Y6g
DossttrcFrEtccolinvoNeaTechTransfcrAgrssmDn{?

ooeglhbD'okcco|lnvotYsad]!9/dev|ce./Produ.t0l3!mgy|eadloyouotrhgNlH
recetornBpay?rlertendr'otroYdrlsf
OVir'(appsnd a staEmert of dMo3ur€)
BNo
Haeths NIHtRP COIGlldB b€6ndisttlbutadlo NIH hvsstigatorFile Typeapplication/pdfFile TitleMicrosoft Word - Attach 26 - BEEA IRB Approvals.docxAuthorMarshall_CFile Modified2010-05-20File Created2010-05-20